Spanish Multiple Sclerosis Network

Recent papers from Spanish Multiple Sclerosis Network

1. Virus-specific effects of disease-modifying therapies on herpesvirus antibody titers in multiple sclerosisScientific Reports · 2026
2. Prevalence of Slowly Expanding Lesions in Patients With Multiple SclerosisNeurology · 2026
3. Kappa index: real-world study for assessing cut-off values that provide the best accuracy for multiple sclerosis diagnosis in patients with CISFrontiers in Immunology · 2026
4. XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part II)Revista de Neurología · 2026
5. XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part I)Revista de Neurología · 2026
6. Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosisBiomedicine & Pharmacotherapy · 2026
7. Multifocal ERG reveals functional retinal changes in multiple sclerosis patients treated with teriflunomide: a 12-month prospective studyScientific Reports · 2026
8. Pregnancy and puerperium imply neuropsychological changes in women: A prospective cohort studyPsychiatry Research Communications · 2026
9. The International Consortium for Arthrogryposis: A Collaborative Framework for Early Detection, Care, Research, and EducationAmerican Journal of Medical Genetics Part C Seminars in Medical Genetics · 2026
10. Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosisBrain · 2026
11. Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing–Remitting Multiple SclerosisInternational Journal of Molecular Sciences · 2026
12. Involvement of autoantibodies against G protein-coupled receptors in post-COVID condition and Chronic Fatigue SyndromeScientific Reports · 2026
13. Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesisScientific Reports · 2026
14. HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosisFrontiers in Immunology · 2026
15. Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosisWorld Allergy Organization Journal · 2026
16. Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing–Remitting Multiple SclerosisJournal of Clinical Medicine · 2026
17. Urinary incontinence, core morphology and their impact on balance and fatigue in multiple sclerosis: an observational studyFrontiers in Neurology · 2026
18. XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)Revista de Neurología · 2026
19. XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)Revista de Neurología · 2026
20. Multiple sclerosis expert patient program in Central America: changes in quality of life and lifestyle habitsNeurodegenerative Disease Management · 2025